menu search

Jasper therapeutics to present at the lifesci partners 2nd annual genetic medicines symposium

REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures wi...

June 23, 2022, 4:05 pm

Zynerba's cannabidiol formulated gel shows encouraging action in genetic disease

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) announced positive top-line results from the Phase 2 INSPIRE trial of Zygel (Transdermal CBD gel) on ped...

June 22, 2022, 10:54 am

Seattle genetics (sgen) moves 12.7% higher: will this strength last?

Seattle Genetics (SGEN) witnessed a jump in share price last session on above-average trading volume. T...

June 20, 2022, 10:06 am

Goodbody health launching cancer and heart disease genetic tests

Goodbody Health Inc (AQSE:GDBY, CSE:GDBY, OTCQB:GDBYF) said it is launching new genetic tests to help p...

June 20, 2022, 2:35 am

Roche (rhhby) alzheimer's disease drug data disappoints

Roche's (RHHBY) study evaluating crenezumab in autosomal dominant Alzheimer's disease did not slow or prevent cognitive decline in people with a speci...

June 16, 2022, 1:52 pm

Bruker (brkr) debuts module on ultima multiphoton microscopes

Bruker's (BRKR) NeuraLight 3D Ultra module offers revolutionary 3D holographic photostimulation to support neuroscience and optog...

June 16, 2022, 1:06 pm

Roche-ac immune's crenezumab fails to show benefit in sub-set of alzheimer's patients

Roche Holdings AG (OTC: RHHBY) said its Alzheimer's medicine crenezumab did not slow or prevent cognitive decline in people with a specific g...

June 16, 2022, 8:36 am

Ac immune shares slide 15% premarket after trial of alzheimer's treatment misses its main goals

Shares of biotech AC Immune SA ACIU, -9.21% slid 15% in premarket trade Thursday, after the company said a a trial of a treatment for Alzheimer's dise...

June 16, 2022, 6:39 am

4 biotech stocks with bright prospects to buy amid recovery

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and G...

June 10, 2022, 1:33 pm

Myriad genetics ceo paul diaz to speak at goldman sachs 43rd annual global healthcare conference

SALT LAKE CITY, June 09, 2022 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics, I...

June 9, 2022, 5:30 pm

4d molecular therapeutics to participate in upcoming june investor conferences

EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harness...

June 2, 2022, 4:02 pm

Why 23andme stock was lagging the market today

The genetics company misses on both the top and bottom lines in its fourth quarter....

May 27, 2022, 2:28 pm

23andme stock falls on widening loss

Shares of 23andMe Holding Co. ME, fell almost 7% in after-hours trading after the genetic-testing compa...

May 26, 2022, 6:51 pm

Biomea fusion to present new preclinical data showing bmf-219's strong activity in relapsed/refractory chronic lymphocytic leukemia (cll) tumor models at asco 2022

REDWOOD CITY, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to dis...

May 26, 2022, 6:30 pm

Reasons to hold on to myriad genetics (mygn) stock for now

Investors are optimistic about Myriad Genetics (MYGN) owing to strong Q1 2022 results and growth in tes...

May 26, 2022, 7:32 am

eneti: buy on discounted valuation, improved outlook, and near-term catalysts

Discussing encouraging first quarter earnings report. Over the past six months, the company has more than doubled its contracted backlog with both 202...

May 26, 2022, 2:00 am

Mainz biomed to participate in h.c. wainwright global investment conference and equity forum german spring conference

BERKELEY, Calif. and MAINZ, Germany, May 17, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a mol...

May 17, 2022, 3:01 am

Sophia genetics sa (soph) ceo jurgi camblong on q1 2022 results - earnings call transcript

SOPHiA GenetiCS SA (NASDAQ:SOPH ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Part...

May 14, 2022, 12:09 pm

23andme to report fy2022 fourth quarter and full year financial results

SUNNYVALE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer g...

May 12, 2022, 4:10 pm

eneti stock slips post q1 results

eneti Inc (NYSE: NETI) reported a first-quarter revenue decline of 62.5% year-over-year to $22.44 mi...

May 12, 2022, 12:06 pm


Search within

Pages Search Results: